These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11822240)

  • 1. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
    Maity S; Sa B; Bandyopadhyay AK
    Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of pulsatile drug delivery system using novel polymer.
    Tekade AR; Gattani SG
    Pharm Dev Technol; 2009; 14(4):380-7. PubMed ID: 19235549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide.
    Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M
    Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ethylcellulose molecular weight on the properties of theophylline microspheres.
    Dashevsky A; Zessin G
    J Microencapsul; 1997; 14(3):273-80. PubMed ID: 9147278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
    Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of molecular weight and porosity on the degradation and drug release from polyglycolide.
    Braunecker J; Baba M; Milroy GE; Cameron RE
    Int J Pharm; 2004 Sep; 282(1-2):19-34. PubMed ID: 15336379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of colon degradation of polysaccharide on the oral bioavailability of theophylline from controlled release hydrophilic matrices.
    Babu GV; Himasankar K; Kumar NR; Murty KV
    Boll Chim Farm; 2003 Dec; 142(10):454-60. PubMed ID: 14971315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
    Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
    AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.